164 related articles for article (PubMed ID: 12009006)
21. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
[TBL] [Abstract][Full Text] [Related]
22. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1.
Wattel A; Kamel S; Prouillet C; Petit JP; Lorget F; Offord E; Brazier M
J Cell Biochem; 2004 May; 92(2):285-95. PubMed ID: 15108355
[TBL] [Abstract][Full Text] [Related]
23. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.
Matsuzaki K; Udagawa N; Takahashi N; Yamaguchi K; Yasuda H; Shima N; Morinaga T; Toyama Y; Yabe Y; Higashio K; Suda T
Biochem Biophys Res Commun; 1998 May; 246(1):199-204. PubMed ID: 9600092
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration.
Voronov I; Heersche JN; Casper RF; Tenenbaum HC; Manolson MF
Biochem Pharmacol; 2005 Jul; 70(2):300-7. PubMed ID: 15919055
[TBL] [Abstract][Full Text] [Related]
25. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T
J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684
[TBL] [Abstract][Full Text] [Related]
26. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts.
Brazier H; Stephens S; Ory S; Fort P; Morrison N; Blangy A
J Bone Miner Res; 2006 Sep; 21(9):1387-98. PubMed ID: 16939397
[TBL] [Abstract][Full Text] [Related]
27. Gene array identification of osteoclast genes: differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte macrophage colony stimulating factor.
Day CJ; Kim MS; Stephens SR; Simcock WE; Aitken CJ; Nicholson GC; Morrison NA
J Cell Biochem; 2004 Feb; 91(2):303-15. PubMed ID: 14743390
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
29. CytokineRegulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation.
Koide M; Maeda H; Roccisana JL; Kawanabe N; Reddy SV
J Bone Miner Res; 2003 Mar; 18(3):458-65. PubMed ID: 12619930
[TBL] [Abstract][Full Text] [Related]
30. Identification of genes differentially expressed in osteoclast-like cells.
Nomiyama H; Egami K; Wada N; Tou K; Horiuchi M; Matsusaki H; Miura R; Yoshie O; Kukita T
J Interferon Cytokine Res; 2005 Apr; 25(4):227-31. PubMed ID: 15812249
[TBL] [Abstract][Full Text] [Related]
31. Benzo[a]pyrene inhibits osteoclastogenesis by affecting RANKL-induced activation of NF-kappaB.
Voronov I; Li K; Tenenbaum HC; Manolson MF
Biochem Pharmacol; 2008 May; 75(10):2034-44. PubMed ID: 18396263
[TBL] [Abstract][Full Text] [Related]
32. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides.
Amcheslavsky A; Bar-Shavit Z
J Cell Physiol; 2006 Apr; 207(1):244-50. PubMed ID: 16402377
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
Zhang YH; Heulsmann A; Tondravi MM; Mukherjee A; Abu-Amer Y
J Biol Chem; 2001 Jan; 276(1):563-8. PubMed ID: 11032840
[TBL] [Abstract][Full Text] [Related]
34. Ly49Q, an ITIM-bearing NK receptor, positively regulates osteoclast differentiation.
Hayashi M; Nakashima T; Kodama T; Makrigiannis AP; Toyama-Sorimachi N; Takayanagi H
Biochem Biophys Res Commun; 2010 Mar; 393(3):432-8. PubMed ID: 20153723
[TBL] [Abstract][Full Text] [Related]
35. YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation.
Shi Z; Silveira A; Patel P; Feng X
Gene; 2004 Dec; 343(1):117-26. PubMed ID: 15563837
[TBL] [Abstract][Full Text] [Related]
36. Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6).
Ogasawara T; Katagiri M; Yamamoto A; Hoshi K; Takato T; Nakamura K; Tanaka S; Okayama H; Kawaguchi H
J Bone Miner Res; 2004 Jul; 19(7):1128-36. PubMed ID: 15176996
[TBL] [Abstract][Full Text] [Related]
37. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts.
Kanno S; Hirano S; Kayama F
Toxicology; 2004 Oct; 203(1-3):211-20. PubMed ID: 15363596
[TBL] [Abstract][Full Text] [Related]
38. Role of ascorbic acid in the osteoclast formation: induction of osteoclast differentiation factor with formation of the extracellular collagen matrix.
Otsuka E; Kato Y; Hirose S; Hagiwara H
Endocrinology; 2000 Aug; 141(8):3006-11. PubMed ID: 10919289
[TBL] [Abstract][Full Text] [Related]
39. Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta ) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast formation.
Hayashi T; Kaneda T; Toyama Y; Kumegawa M; Hakeda Y
J Biol Chem; 2002 Aug; 277(31):27880-6. PubMed ID: 12023971
[TBL] [Abstract][Full Text] [Related]
40. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation.
Kim MS; Day CJ; Morrison NA
J Biol Chem; 2005 Apr; 280(16):16163-9. PubMed ID: 15722361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
